Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-35.27M
↑ 19% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-43.57M
Historical baseline
PeriodValueYoY Change
2025$-35.27M+41.3%
2024$-60.12M-40.5%
2023$-42.79M+31.7%
2022$-62.68M-11.5%
2021$-56.22M-62.2%
2020$-34.67M+45.0%
2019$-63.07M-58.9%
2018$-39.70M-76.5%
2017$-22.49M-20.3%
2016$-18.70M-